Hereditary spherocytosis overview: Difference between revisions

Jump to navigation Jump to search
m (Template)
Line 7: Line 7:


==Historical Perspective==
==Historical Perspective==
* Towards the end of the nineteenth century Vanlair and Masius described the case of a young woman who developed icterus, recurrent attacks of left upper quadrant abdominal pain and [[splenomegaly]] shortly after giving birth. The [[stools]] were not light coloured, but rather deeply pigmented. The patient's mother and sister were also [[Icterus|icteric]], and the sister's [[spleen]]<nowiki/>was enlarged.


==Classification==
==Classification==
* Hereditary Spherocytosis classified on basis of underlying defect in protein and also on the basis of severity of hemolysis.


==Pathophysiology==
==Pathophysiology==
There is intrinsic defects in erythrocyte membrane proteins that result in [[Red blood cell|RBC]] [[cytoskeleton]] instability. Loss of erythrocyte surface area leads to the spherical shape of RBCs (spherocytes), which are culled rapidly from the circulation by the [[spleen]]. [[Hemolysis]] mainly confined to the spleen and, therefore, is extravascular. Splenomegaly commonly develops.
The following four abnormalities in RBC membrane proteins have been identified in HS:
* [[Spectrin]] deficiency alone
* Combined [[spectrin]] and [[ankyrin]] deficiency
* [[Band 3|Band 3 deficiency]]
* [[Protein 4.2]] defects


==Causes==
==Causes==
* [[Hereditary spherocytosis|HS]] is caused by a variety of [[mutations]] that lead to defects in [[Red blood cells|red blood cell (RBC)]] membrane proteins. HS usually is transmitted as an [[autosomal dominant]] trait, and the identification of the disorder in multiple [[Generation|generations]] of affected families is the rule. [[Homozygosity]] for this dominantly transmitted [[Hereditary spherocytosis|HS]] [[gene]] has not been identified, which suggests that the [[homozygous]] state is incompatible with life.


==Differentiating {{PAGENAME}} from Other Diseases==
==Differentiating {{PAGENAME}} from Other Diseases==


==Epidemiology and Demographics==
==Epidemiology and Demographics==
* HS is seen in all populations but appears to be especially common in people of northern European ancestry.
* In the United States, the incidence of the disorder is approximately one case in 5000 people.
** In northern European, HS affects as many as 1 in 2000 to 1 in 5000 (prevalence, approximately 0.02 to 0.05 percent).


==Risk Factors==
==Risk Factors==

Revision as of 09:56, 2 August 2018

Hereditary spherocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary spherocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary spherocytosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary spherocytosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary spherocytosis overview

CDC on Hereditary spherocytosis overview

Hereditary spherocytosis overview in the news

Blogs on Hereditary spherocytosis overview

Directions to Hospitals Treating Hereditary spherocytosis

Risk calculators and risk factors for Hereditary spherocytosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hereditary spherocytosis is a genetically-transmitted form of spherocytosis, an auto-hemolytic anemia characterized by the production of red blood cells that are sphere-shaped rather than donut-shaped, and therefore more prone to hemolysis.

Historical Perspective

  • Towards the end of the nineteenth century Vanlair and Masius described the case of a young woman who developed icterus, recurrent attacks of left upper quadrant abdominal pain and splenomegaly shortly after giving birth. The stools were not light coloured, but rather deeply pigmented. The patient's mother and sister were also icteric, and the sister's spleenwas enlarged.

Classification

  • Hereditary Spherocytosis classified on basis of underlying defect in protein and also on the basis of severity of hemolysis.

Pathophysiology

There is intrinsic defects in erythrocyte membrane proteins that result in RBC cytoskeleton instability. Loss of erythrocyte surface area leads to the spherical shape of RBCs (spherocytes), which are culled rapidly from the circulation by the spleen. Hemolysis mainly confined to the spleen and, therefore, is extravascular. Splenomegaly commonly develops.

The following four abnormalities in RBC membrane proteins have been identified in HS:

Causes

Differentiating Hereditary spherocytosis overview from Other Diseases

Epidemiology and Demographics

  • HS is seen in all populations but appears to be especially common in people of northern European ancestry.
  • In the United States, the incidence of the disorder is approximately one case in 5000 people.
    • In northern European, HS affects as many as 1 in 2000 to 1 in 5000 (prevalence, approximately 0.02 to 0.05 percent).

Risk Factors

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

Template:WS Template:WH